Nuria Isern

Optimapharm

Optimapharm is a leading, mid-sized, full-service CRO working across Europe and North America to deliver new therapies to improve and save patients' lives. Optimapharm's key priorities are our people and consistently exceeding our client's expectations. With 27 strategically located offices across Europe, Optimapharm operates in 41 countries, giving unrivaled access to Patients and Investigators in all countries in Europe and North America. In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years. Companies Figures • 510+ employees • Excellence in delivery and superior project performance with an investigator network of 1000+ active sites • Close client relationship & high client retention rate of 85% • Highly educated workforce & low staff turnover rate; less than 15%, across the organization • Regional Cost-effective solutions ==== Full-service study delivery, Stand-alone service and Functional Service Provider are the 3 pillars Optimapharm offers to best respond to planned clinical development and efficiently resource clinical projects. • Regulatory Affairs • Medical Affairs • Medical Writing • Clinical Monitoring • Project Management • Data Management • Biostatistics • Safety and Vigilance • Quality • Translation Services OPTIMAPHARM's offices: - Austria - Belgium - Bosnia and Herzegovina - Bulgaria - Croatia - Czech Republic - Estonia - Finland - France - Georgia - Germany - Greece - Hungary - Latvia - Lithuania - Republic of North Macedonia - Moldova - Poland - Romania - Serbia - Slovenia - Spain - Sweden - Switzerland - The United Kingdom - The United States of America